What is aTyr Pharma's EPS (basic)?

aTyr Pharma (ATYR) reported EPS (basic) of -$0.11 in Q1 2026.

How has aTyr Pharma's EPS (basic) changed year-over-year?

aTyr Pharma's EPS (basic) increased by 35.3% year-over-year, from -$0.17 to -$0.11.

What is the long-term trend for aTyr Pharma's EPS (basic)?

Over 4 years (2021 to 2025), aTyr Pharma's EPS (basic) has grown at a -18.4% compound annual growth rate (CAGR), from -$1.78 to -$0.79.

What does EPS (basic) mean?

Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.

aTyr Pharma ATYR EPS (Basic)

EPS (Basic) at other companies

Bristol-Myers SquibbBMY

$1.31+8.3%

Merck & Co.MRK

-$1.72-186%

United TherapeuticsUTHR

$6.32-12.0%

Design Therapeutics, Inc.DSGN

-$0.29+6.5%

CytomX TherapeuticsCTMX

-$0.10-137%

Vor BiopharmaVOR

-$5.11+1.9%

Other financials

Income statement

See full

Revenue-—

Operating income-$11.4M+27.5%

Net income-$10.8M+27.5%

EPS (diluted)-$0.11+35.3%

Balance sheet

See full

Cash & equivalents$10.0M-3.4%

Total debt$12.3M-9.2%

Total equity$57.9M-22.8%

Total assets$79.7M-18.1%

Cash flow

See full

Operating cash flow-$12.5M+18.8%

CapEx$138.0K—

Free cash flow-$12.7M+17.9%

Valuation

See full

Market cap$54.88M-88.2%

Enterprise value$57.17M—

P/S288.8×—

Profitability

See full

Operating margin-40,856.3%+28,833pp

Net margin-39,009.5%+29,653pp

FCF margin-32,664.7%+4,018pp

Returns & leverage

See full

Return on equity-105.3%+50.6pp

Debt / equity0.2×0.0×

Current ratio5.8×-2.0×

Where this comes from

Reported directly by aTyr Pharma in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.

The official record: aTyr Pharma’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about aTyr Pharma's eps (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is aTyr Pharma's EPS (basic)?: aTyr Pharma (ATYR) reported EPS (basic) of -$0.11 in Q1 2026.
How has aTyr Pharma's EPS (basic) changed year-over-year?: aTyr Pharma's EPS (basic) increased by 35.3% year-over-year, from -$0.17 to -$0.11.
What is the long-term trend for aTyr Pharma's EPS (basic)?: Over 4 years (2021 to 2025), aTyr Pharma's EPS (basic) has grown at a -18.4% compound annual growth rate (CAGR), from -$1.78 to -$0.79.
What does EPS (basic) mean?: Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.